Objective: To explore the safety and superiority of laparoscopic surgery for benign ovarian tumor.
目的：探讨腹腔镜下卵巢良性肿瘤手术的安全性及优越性。
Methods Immunohistochemistrical SP method was used to detect the expression of EGFR in 15 cases of normal ovarian tissue and 15 cases of benign ovarian tumor and 60 cases ovarian cancer.
方法应用免疫组织化学法(SP方法)，检测15例正常卵巢组织，15例卵巢良性肿瘤组织及60例卵巢癌组织中egfr的表达情况。
Methods The expressions of P21 and P27 protein in normal ovarian tissue(10 cases), benign ovarian tumor (10 cases) and ovarian carcinoma (30 cases) were analyzed by immunohistochemistry technique.
方法应用免疫组织化学方法检测10份正常卵巢组织、10份良性卵巢肿瘤以及30份恶性卵巢肿瘤组织中P21和P27蛋白的表达。
Objective to investigate the tumor angiogenesis in benign borderline and malignant epithelial ovarian tumors and its relationship with the tumorigenesis.
目的探讨良性、界性和恶性上皮性卵巢肿瘤微血管生成状态及肿瘤微血管生成与卵巢肿瘤发生、展的关系。
The positive rate of EGFR was 40.0% in ovarian benign tumor, and was 80.0% in ovarian cancer.
EGFR在良性卵巢肿瘤组织中的阳性表达率分别为40.0%，在卵巢癌组织中的阳性表达率为80.0%；
Method: The data of laparoscopic surgery for 178 patients with ovarian benign tumor were retrospectively summarized.
方法：对行腹腔镜手术治疗的178例卵巢良性肿瘤患者资料进行回顾性总结。
Conclusion: CA125 is not only a marker for ovarian cancer, but a broad-spectrum tumor marker. There are higher positive rates of CA125 in some benign diseases including hepatocirrhosis.
结论CA125不只是卵巢癌的指标，也是一种广谱肿瘤标志物，并且肝硬化等良性疾病也有较高的阳性率，可作为健康体检中筛选异常人群的指标。
The results showed that the levels of three tumor markers in ovarian cancer patients were significantly higher than those in benign tumor patients and controls(P<0. 05).
结果显示：卵巢癌组与良性肿瘤组和对照组相比，三项标志物的血清含量有显著性差异（P<0．05）。
Objective: To assess the efficacy of laparoscopy in the treatment of puberty ovarian benign tumor.
目的：探讨腹腔镜下卵巢良性肿瘤手术的适用性、安全性及优越性。
Conclusions 1. PA lacks the specificity for diagnosis of human malignancies, however, it would be used as a tumor marker to differentiate ovarian cancers from women with benign pelvic masses.
结论：PA对人类恶性肿瘤缺乏特异性，但可作为鉴别卵巢良、恶性病变的有价值标志物。
Conclusions 1. PA lacks the specificity for diagnosis of human malignancies, however, it would be used as a tumor marker to differentiate ovarian cancers from women with benign pelvic masses.
结论：PA对人类恶性肿瘤缺乏特异性，但可作为鉴别卵巢良、恶性病变的有价值标志物。
应用推荐